| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 1173-1185, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
TR Ulich, KZ Guo, B Irwin, DG Remick and GN Davatelis
Department of Pathology, University of California, Irvine School of Medicine 92717.
Tumor necrosis factor alpha (TNF alpha) mRNA is present in a preformed intracellular pool in the spleen, liver, and small bowel of naive rats. Endotoxin (Salmonella typhus lipopolysaccharide) injected intravenously induces little or no increase in whole-organ TNF mRNA levels at 15', 30', 1 degree, 2 degrees, or 4 degrees, whereas serum TNF levels are markedly elevated at 1 and 2 hours. Dexamethasone pretreatment of rats suppresses LPS-induced serum TNF concentrations, but does not suppress TNF mRNA levels in the spleen or bowel. Tachyphylaxis experiments demonstrate that a second injection of endotoxin 2 hours after an initial injection fails to induce a second peak of serum TNF, although TNF mRNA levels in the spleen and bowel remain at the levels found in naive rats. Corynebacterium parvum upregulates endotoxin-induced serum TNF release and intravenous injection of IL-1 induces the release of serum TNF but neither alters whole-organ TNF mRNA levels. Interleukin-1 alpha (IL-1 alpha) mRNA was not constitutively detected in whole-organ RNA preparations of the spleen, liver, and small bowel of naive rats. Endotoxin induces IL-1 alpha mRNA most easily appreciated in the spleen beginning at 1 hour, peaking at 2 to 4 hours, and disappearing by 6 hours. Interleukin-1 beta (IL-1 beta) mRNA was not constitutively detected in the organs examined or was present in small amounts. Endotoxin induces IL-1 beta mRNA beginning at 0.5 hours, peaking at 1 hour, and disappearing by 6 hours. Dexamethasone pretreatment prevents the LPS-induced appearance of IL-1 alpha mRNA and suppresses but does not completely inhibit the appearance of IL-1 beta mRNA. C. parvum upregulates endotoxin-induced IL-1 mRNA expression. Intravenous injection of TNF or IL-1 both induce IL-1 mRNA expression. In conclusion, TNF mRNA is constitutively expressed and TNF mRNA levels as analyzed in whole-organ RNA preparations do not change in concert with serum TNF protein levels during conditions of endotoxemia, dexamethasone treatment, tachyphylaxis, priming with C. parvum, or after injection of IL-1. In contrast, IL-1 mRNA expression during endotoxemia, dexamethasone treatment, priming with C. parvum, or after injection of TNF or IL-1 shows clear increases and decreases in whole- organ RNA preparations.
This article has been cited by other articles:
 |
|
 |
|
  M. B. B. McCall, M. G. Netea, C. C. Hermsen, T. Jansen, L. Jacobs, D. Golenbock, A. J. A. M. van der Ven, and R. W. Sauerwein Plasmodium falciparum Infection Causes Proinflammatory Priming of Human TLR Responses J. Immunol., July 1, 2007; 179(1): 162 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kresse, M. Latta, G. Kunstle, H.-M. Riehle, N. van Rooijen, H. Hentze, G. Tiegs, M. Biburger, R. Lucas, and A. Wendel Kupffer Cell-Expressed Membrane-Bound TNF Mediates Melphalan Hepatotoxicity via Activation of Both TNF Receptors J. Immunol., September 15, 2005; 175(6): 4076 - 4083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Knott, D. P. O'Brien, R. J. Juno, Y. Zhang, J. L. Williams, C. R. Erwin, and B. W. Warner Enterocyte apoptosis after enterectomy in mice is activated independent of the extrinsic death receptor pathway Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G404 - G413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Diffee, K. Kalfas, S. Al-Majid, and D. O. McCarthy Altered expression of skeletal muscle myosin isoforms in cancer cachexia Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1376 - C1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kadokami, C. F. McTiernan, T. Kubota, C. S. Frye, G. S. Bounoutas, P. D. Robbins, S. C. Watkins, and A. M. Feldman Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2281 - H2291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. BHALLA, S. W. WILCZYNSKI, A. M. ABUSHAMAA, W. P. PETROS, C. S. MCDONALD, J. S. LOFTIS, N. J. CHAO, J. J. VREDENBURGH, and R. J. FOLZ Pulmonary Toxicity of Induction Chemotherapy Prior to Standard or High-dose Chemotherapy with Autologous Hematopoietic Support Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 17 - 25. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. S. Thorne, P. B. McCray Jr., T. S. Howe, and M. A. O'Neill Early-Onset Inflammatory Responses In Vivo to Adenoviral Vectors in the Presence or Absence of Lipopolysaccharide-Induced Inflammation Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1155 - 1164. [Abstract] [Full Text]
|
|
|
|
|
|
H. Tsuji, N. Mukaida, A. Harada, S. Kaneko, E. Matsushita, Y. Nakanuma, H. Tsutsui, H. Okamura, K. Nakanishi, Y.-i. Tagawa, et al. Alleviation of Lipopolysaccharide-Induced Acute Liver Injury in Propionibacterium acnes-Primed IFN-{gamma}-Deficient Mice by a Concomitant Reduction of TNF-{alpha}, IL-12, and IL-18 Production J. Immunol., January 15, 1999; 162(2): 1049 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Schepp, K. Dehne, H. Herrmuth, K. Pfeffer, and C. Prinz Identification and functional importance of IL-1 receptors on rat parietal cells Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1094 - G1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, D.H. Mitchell, and D.L. Coleman Lipopolysaccharide induces expression of Egr-1 in macrophages through upstream CArG box (serum response) elements Innate Immunity, August 1, 1995; 2(4): 239 - 246. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
